Menstrual Changes and Hypothyroidism: Heavy, Irregular, or Missed Periods

Hypothyroidism commonly causes menorrhagia, anovulation, and luteal phase defects. Most menstrual irregularities normalize within 3 to 6 months of adequate levothyroxine. Persistent heavy bleeding or amenorrhea warrants a gynecologic workup, and any woman bleeding heavily for months should have ferritin checked.

Why hypothyroidism disrupts the menstrual cycle

The menstrual cycle depends on a tightly coordinated signal chain: hypothalamus → pituitary → ovary → endometrium. Thyroid hormone influences every step of that chain, so when T4 and T3 fall, the cycle drifts off-pattern through several mechanisms that can act at the same time [C2][C3].

• Elevated TRH drives prolactin up. In primary hypothyroidism, low T4 triggers the hypothalamus to release more TRH (thyrotropin-releasing hormone). TRH stimulates the pituitary to make TSH — but it also stimulates prolactin release. Mild hyperprolactinemia suppresses GnRH pulses, blunting the LH surge that triggers ovulation. The result is anovulation, oligomenorrhea, or amenorrhea [C2][C3].
• SHBG falls, free estrogen rises. Thyroid hormone is a key driver of hepatic sex hormone-binding globulin (SHBG) production. Hypothyroidism lowers SHBG, which raises free (bioavailable) estrogen and shifts the estrogen-to-progesterone balance. This contributes to endometrial proliferation, heavier flow, and breakthrough bleeding [C3][C7].
• Estrogen metabolism is altered. Hypothyroidism shifts estrogen metabolism toward less protective metabolites and reduces hepatic clearance, prolonging estrogen exposure to the endometrium [C3].
• Coagulation factors decrease. Severe hypothyroidism lowers factors VII, VIII, IX, and XI and impairs platelet adhesion, which can worsen menstrual blood loss in an already estrogen-stimulated endometrium [C2].
• Anovulation produces unopposed estrogen. Without ovulation, no corpus luteum forms, no progesterone is secreted, and the endometrium builds up under estrogen alone — eventually shedding heavily and irregularly [C3][C7].

The same mechanisms are amplified in Hashimoto's thyroiditis because the autoimmune process can also affect ovarian reserve and the implantation window through anti-thyroid antibodies, independent of TSH [C5][C7].

The clinical pattern by severity

The pattern of menstrual change roughly tracks the depth of hypothyroidism [C2][C3]:

• Subclinical or mild hypothyroidism (TSH 4–10 mIU/L). Most women still cycle regularly. Subtle changes include slightly heavier or longer flow, mild luteal phase shortening, or mildly elevated prolactin. Many are asymptomatic from a cycle standpoint.
• Overt hypothyroidism (TSH >10 mIU/L, low free T4). The most common pattern is menorrhagia — heavier, longer periods, sometimes with passage of clots. Anovulatory cycles become more frequent, cycle length lengthens, and luteal phase defects appear. Krassas's classic series found menstrual disturbances in roughly 23–35% of overtly hypothyroid women, dominated by menorrhagia and oligomenorrhea [C2].
• Severe, long-standing hypothyroidism. Amenorrhea can occur, often driven by significant hyperprolactinemia. Galactorrhea (milk discharge unrelated to pregnancy) can accompany it. This pattern is most common before treatment is started or when treatment has been interrupted for months [C2][C3].

What recovers on adequate levothyroxine

Most thyroid-driven menstrual changes are reversible once TSH stabilizes in the normal range [C1][C2][C3]:

• Weeks 4–8: Prolactin typically normalizes as TRH drive falls. Galactorrhea, if present, usually resolves first.
• Months 1–3: Cycle length tends to regularize. Bleeding volume begins to decrease in women who had menorrhagia.
• Months 3–6: Ovulation resumes in most cases. Luteal phase length normalizes. SHBG rises back toward normal, rebalancing free estrogen.
• Months 6+: Fertility recovers in most women with previously hypothyroid-driven anovulation; ovarian reserve markers (AMH, antral follicle count) generally stabilize at the woman's age-expected level [C7].

Patients should know that the cycle is one of the slower-to-fully-normalize systems — a cycle takes around a month, so visible "regularization" requires several cycles to confirm. The first one or two cycles on a new dose can still look abnormal even when biochemistry has improved [C1][C6].

When menstrual issues persist despite a normal TSH

If bleeding, irregularity, or amenorrhea continues past 6 months of stable, in-range TSH, the issue is unlikely to be thyroid alone. The differential broadens to include [C2][C3][C7]:

1. Polycystic ovary syndrome (PCOS). Hashimoto's and PCOS co-occur more often than chance, and PCOS is the most common cause of anovulatory bleeding in reproductive-age women. See the thyroid-pcos article.
2. Structural uterine causes. Fibroids, polyps, adenomyosis, and (less often) endometrial hyperplasia all cause heavy or irregular bleeding. A pelvic ultrasound is the standard first step.
3. Bleeding disorders. Von Willebrand disease and platelet function disorders are under-diagnosed causes of lifelong menorrhagia.
4. Other endocrine causes. Hyperprolactinemia not driven by TRH (pituitary microadenoma), premature ovarian insufficiency, hypothalamic amenorrhea from energy deficit, and primary ovarian causes.
5. Iron-deficiency anemia from the bleeding itself. Long-standing menorrhagia depletes iron, which independently worsens fatigue, hair loss, and the perceived burden of thyroid symptoms. See iron-deficiency-thyroid.
6. Over-replacement of levothyroxine. A suppressed TSH (below 0.1 mIU/L) acts like subclinical hyperthyroidism and can shorten cycles, cause spotting, or trigger anovulation [C1][C8]. The fix is dose reduction, not adding hormones.

What does NOT help

Several heavily-marketed approaches lack evidence for thyroid-related menstrual changes [C1][C6]:

• "Hormone-balancing" supplement stacks — usually combinations of vitex (chasteberry), DIM, maca, ashwagandha, and iodine. Iodine can destabilize Hashimoto's; ashwagandha has documented thyrotoxicosis risk; vitex affects prolactin in ways that have not been tested alongside levothyroxine.
• Switching to "natural desiccated thyroid" to fix periods. The 2014 ATA guideline recommends levothyroxine as first-line; there is no trial showing NDT normalizes cycles faster than well-titrated levothyroxine [C1].
• High-dose iodine. Iodine is essential, but supraphysiologic doses can worsen autoimmune thyroiditis and do not improve cycle regularity in iodine-replete women.
• "Adrenal" or "thyroid-adrenal-ovarian axis" supplements. No clinical trials support these for menstrual normalization in hypothyroidism.

The right path is reliably correct levothyroxine dosing, ferritin replacement if anemia is present, and gynecology if bleeding does not respond [C1][C6].

Practical guidelines

1. Confirm TSH is in the target range. Most thyroid-driven menstrual changes resolve once TSH is stable in the normal range (typically 0.5–2.5 mIU/L for symptomatic targets) [C1].
2. Check ferritin if you have had heavy periods for more than 2–3 months. Iron-deficiency anemia is common after months of menorrhagia and worsens hypothyroid symptoms; aim for ferritin above 30–40 ng/mL [C1].
3. Give the cycle 3 to 6 months after reaching target TSH. A single abnormal cycle on a new dose is not a treatment failure — the pituitary–ovarian axis takes several cycles to resynchronize [C2][C3].
4. Ask your endocrinologist to check prolactin if amenorrhea persists beyond 3–6 months at a normal TSH [C2][C3].
5. See gynecology if bleeding is heavy enough to soak through protection hourly, lasts more than 7 days, or includes large clots — this needs evaluation regardless of TSH [C2].
6. If you are trying to conceive, your endocrinologist will likely target TSH below 2.5 mIU/L before conception and reassess promptly once pregnancy is confirmed; see thyroid-pregnancy-fertility [C1][C7].

Frequently asked questions

Why do I bleed so heavily with hypothyroidism? Low thyroid hormone lowers SHBG and raises free estrogen, increases endometrial proliferation, reduces clotting factor activity, and often leads to anovulatory cycles where progesterone never opposes the estrogen build-up. The combination produces heavier, longer bleeds [C2][C3].

Will my periods go back to normal on levothyroxine? Most women see meaningful improvement within 3 to 6 months of reaching a stable, normal TSH. Cycles usually regularize first, then bleeding volume normalizes, then ovulation resumes [C1][C2][C3].

Can hypothyroidism cause missed periods? Yes. Severe or long-standing hypothyroidism can produce amenorrhea, usually mediated by TRH-driven hyperprolactinemia. It is reversible once thyroid hormone and prolactin normalize [C2][C3].

Does Hashimoto's affect fertility even when my TSH is normal? Possibly, but modestly. Anti-thyroid antibodies are associated with slightly lower ovarian reserve and higher miscarriage risk in some studies, independent of TSH. The effect is smaller than the effect of untreated hypothyroidism itself [C5][C7].

Could heavy periods be a sign of over-treatment? Less commonly. Over-replacement (TSH below 0.1 mIU/L) can cause spotting or short cycles, but not classic menorrhagia. Heavy, prolonged bleeding more often points to under-treatment, iron deficiency, or a structural uterine cause [C1][C8].

Bottom line

Menstrual changes are a recognized and frequent feature of hypothyroidism, driven by TRH-mediated prolactin elevation, low SHBG, altered estrogen metabolism, and anovulation [C2][C3]. The clinical pattern scales with severity — menorrhagia in moderate disease, amenorrhea in severe disease. Most cycles normalize within 3 to 6 months of reaching a stable normal TSH on levothyroxine [C1]. Persistent menorrhagia or amenorrhea past that window warrants gynecologic evaluation and a ferritin check; over-treatment, PCOS, and structural uterine disease are the usual alternative explanations [C2][C7][C8]. The correct levothyroxine dose, patience across several cycles, and a low threshold to involve gynecology are the high-value moves [C1][C6].

Sources

1. [C1] Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670–1751. PubMed: 25266247
2. [C2] Krassas GE et al. Disturbances of menstruation in hypothyroidism. Clin Endocrinol (Oxf). 1999. PubMed: 10468932
3. [C3] Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev. 2010. PubMed: 20573783
4. [C4] Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348(26):2646–2655. PubMed: 12826640
5. [C5] Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4-5):391–397. PubMed: 24434360
6. [C6] American Thyroid Association. Hypothyroidism — Patient Information. thyroid.org
7. [C7] Iwase A et al. Autoimmune Thyroid Disease and Female Fertility: Clinical Evidence on Ovarian Reserve, Infertility Treatment Outcomes, and Pathophysiology. 2026. PubMed: 42004411
8. [C8] Baskaran BS et al. Risk of cardiac, neuropsychiatric and musculoskeletal adverse events with levothyroxine: Systematic review. 2026. PubMed: 41559017

---

For educational purposes only. Not medical advice. Always consult your healthcare provider.